Search results
French Open 2024 results: Aryna Sabalenka and Elena Rybakina reach quarter-finals
BBC News· 5 days agoAryna Sabalenka sent an ominous message to her rivals as she powered past Emma Navarro to reach the...
Novak Djokovic injured in French Open five-setter, unsure about playing quarterfinal
NBC Sports via Yahoo Sports· 5 days agoOpen. The last Australian man to make the French Open quarterfinals was Lleyton Hewitt in 2004. De...
Australia should force Meta to pay for news, News Corp executive says
Reuters· 4 days agoMeta said in March it would stop paying Australian news publishers for content. "Meta must be...
NIO (NYSE:NIO) Announces Earnings Results, Misses Expectations By $0.05 EPS
ETF DAILY NEWS· 5 hours agoNIO (NYSE:NIO – Get Free Report) posted its earnings results on Thursday. The company reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.05 ...
French Open: 17-year-old Mirra Andreeva, 28-year-old Jasmine Paolini pull off upsets to make first...
WSB Radio· 3 days agoThere will be two first-timers in the 2024 French Open women's semifinal. 17-year-old Mirra Andreeva...
Jasmine Paolini, Mirra Andreeva and the different paths to unexpected French Open semi-final
The Independent via Yahoo Sports· 2 days agoGarros before and offered little resistance. Their 2022 final was one-sided, as was their...
French Open day 10 preview: Carlos Alcaraz 'will ignite flame' for Stefanos Tsitsipas
BBC News· 5 days agoStefanos Tsitsipas says his French Open quarter-final with Carlos Alcaraz on Tuesday will "ignite my...
Novak Djokovic’s French Open Withdrawal Leaves Season in Doubt
Sports Illustrated· 4 days agoThe shock result of Tuesday at Roland Garros didn’t involve the tennis ball being struck. Less than...
2024 Australian Olympic Trials: Remembering Thorpie’s Fall 20 Years On – Expect the Unexpected
Swimming World Magazine· 2 days agoAs the Australian Olympic Trials get set to begin, it's been 20 years since legend Ian Thorpe...
Iterum Therapeutics’ (ITRM) “Buy” Rating Reiterated at HC Wainwright
ETF DAILY NEWS· 6 days agoIterum Therapeutics (NASDAQ:ITRM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a note issued to investors on Friday, Benzinga reports ...